Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

13.6%

3 terminated/withdrawn out of 22 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

41%

9 trials in Phase 3/4

Results Transparency

89%

8 of 9 completed trials have results

Key Signals

6 recruiting8 with results

Enrollment Performance

Analytics

Phase 3

5(35.7%)

Phase 4

4(28.6%)

N/A

3(21.4%)

Phase 2

1(7.1%)

Phase 1

1(7.1%)

14Total

Phase 3(5)

Phase 4(4)

N/A(3)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials

NCT05435157Completed

Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.

Role: lead

NCT06713837Phase 3Recruiting

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Role: collaborator

NCT06459024Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06961175Recruiting

Observational Study of Platelet Dysfunction Assessed by Thromboelastography in Cardiovascular Surgery (DISPLATEG)

Role: lead

NCT05419947Phase 4Completed

Clinical Trial for the Optimization of Indocyanine Green Administration in NIRF-C During L.Cholecystectomy.

Role: lead

NCT03739476Phase 3Terminated

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Role: lead

NCT04355013Completed

Temperature Monitoring in Cardiac Surgery: Agreement Between Different Clinical Methods

Role: lead

NCT03711110Not ApplicableRecruiting

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

Role: lead

NCT04765943Active Not Recruiting

Prognosis Impact of NSVTs After an AMI (TeVeO Study).

Role: lead

NCT03850756Completed

Early Diagnosis of Kidney Damage Associated With Tobacco Use

Role: lead

NCT04780581Phase 4Terminated

Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients

Role: lead

NCT05086939Phase 3Active Not Recruiting

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Role: lead

NCT04773301Phase 4Completed

Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly

Role: lead

NCT05785988Recruiting

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Role: collaborator

NCT04386135Unknown

DESVELA. Personal Skills as Determinants of Morbidity, Lifestyles, Quality of Life, Use of Services and Mortality.

Role: collaborator

NCT03570450Phase 1Recruiting

Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1

Role: collaborator

NCT03057184Not ApplicableCompleted

Behavioral Problems Related to Attendance Adult Day Care Centers

Role: collaborator

NCT05071417Phase 3Unknown

Effect Of Semaglutide In Coronary Atheroma Plaque

Role: lead

NCT02849613Phase 2Withdrawn

Regenerative Stem Cell Therapy for Stroke in Europe

Role: collaborator

NCT03702010Not ApplicableCompleted

Spinal Cord Stimulation in Patients With Post-Laminectomy Syndrome in Testing Phase

Role: lead